Sichuan Kelun-Biotech Biopharmaceutical Co (HKSE:06990) Other Current Liabilities : HK$704.9 Mil (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Sichuan Kelun-Biotech Biopharmaceutical Co Other Current Liabilities?

Sichuan Kelun-Biotech Biopharmaceutical Co's other current liabilities for the quarter that ended in Dec. 2023 was HK$704.9 Mil.

Sichuan Kelun-Biotech Biopharmaceutical Co's quarterly other current liabilities increased from Dec. 2022 (HK$927.5 Mil) to Jun. 2023 (HK$2,927.4 Mil) but then declined from Jun. 2023 (HK$2,927.4 Mil) to Dec. 2023 (HK$704.9 Mil).

Sichuan Kelun-Biotech Biopharmaceutical Co's annual other current liabilities increased from Dec. 2021 (HK$848.4 Mil) to Dec. 2022 (HK$927.5 Mil) but then declined from Dec. 2022 (HK$927.5 Mil) to Dec. 2023 (HK$704.9 Mil).

Sichuan Kelun-Biotech Biopharmaceutical Co Other Current Liabilities Historical Data

The historical data trend for Sichuan Kelun-Biotech Biopharmaceutical Co's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sichuan Kelun-Biotech Biopharmaceutical Co Other Current Liabilities Chart

Sichuan Kelun-Biotech Biopharmaceutical Co Annual Data

Trend

Dec21

Dec22

Dec23

Other Current Liabilities

Sichuan Kelun-Biotech Biopharmaceutical Co Quarterly Data
	Sep21	Dec21	Jun22	Sep22	Dec22	Jun23	Dec23
Other Current Liabilities	Get a 7-Day Free Trial			-	-	-	-	-

Sichuan Kelun-Biotech Biopharmaceutical Co Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

Sichuan Kelun-Biotech Biopharmaceutical Co Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Sichuan Kelun-Biotech Biopharmaceutical Co's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Sichuan Kelun-Biotech Biopharmaceutical Co (HKSE:06990) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sichuan Kelun-Biotech Biopharmaceutical Co Ltd (HKSE:06990) » Definitions » Other Current Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 666 Xinhua Avenue, Chengdu Cross-Strait Science and Technology Industry Development Park, Wenjiang, Sichuan, Chengdu, CHN

Website

http://www.kelun-biotech.com

Sichuan Kelun-Biotech Biopharmaceutical Co Ltd is an innovative biopharmaceutical company committed to the R&D, manufacturing and commercialization of novel drugs to address medical needs in China and globally. It is one of the first movers in the development of antibody-drug conjugates (ADCs), with over a decade of accumulated experience in ADC development. The company takes a systematic, indication-oriented approach to target the world's prevalent or hard-to-treat cancers, and other diseases and conditions affecting a large and underserved population.

Sichuan Kelun-Biotech Biopharmaceutical Co (HKSE:06990) Headlines

No Headlines